e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Ocak S., Sos M. L., Thomas R. K., Massion P. P.
Source:
Eur Respir J 2009; 33: 489-506
Journal Issue:
August
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ocak S., Sos M. L., Thomas R. K., Massion P. P.. High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications. Eur Respir J 2009; 33: 489-506
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006
New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009
Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Source: Eur Respir J 2013; 42: 802-825
Year: 2013
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Radiomics in lung cancer: progress and challenges
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Modern molecular lung cancer diagnostics – how to use and interpret it wisely
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018
The biology of lung cancer
Source: Eur Respir Mon; 2009: 44: 88–105
Year: 2009
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Stem cells, lung pathogenesis and therapeutic potential
Source: Annual Congress 2005 - Scientific year in review
Year: 2005
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
The electronic nose: emerging biomarkers in lung cancer diagnostics
Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019
Year: 2019
The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002
Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept